A Study to Evaluate the Safety and Immune Response of mRNA-1345, a Vaccine Targeting Respiratory Syncytial Virus (RSV), When Co-administered With a Fluzone HD, in Adults ≥65 Years of Age

PHASE3CompletedINTERVENTIONAL
Enrollment

1,900

Participants

Timeline

Start Date

September 25, 2023

Primary Completion Date

June 7, 2024

Study Completion Date

June 7, 2024

Conditions
Respiratory Syncytial Virus
Interventions
BIOLOGICAL

Placebo

0.9% sodium chloride (normal saline) injection

BIOLOGICAL

mRNA-1345

Suspension for injection

BIOLOGICAL

Fluzone HD

Suspension for injection

Trial Locations (34)

19107

DM Clinical Research - Philadelphia, Philadelphia

28403

Trial Management Associates, LLC, Wilmington

29303

Spartanburg Medical Research, Spartanburg

30281

Clinical Research Atlanta/Headlands, Stockbridge

32819

Headlands Research - Orlando, Orlando

33016

Neoclinical Research, Hialeah

33135

South Florida Research Center, Inc., Miami

33173

Suncoast Research Associates, LLC, Miami

33458

Health Awareness INC, Jupiter

33603

New Tampa Health, Inc, Tampa

37075

Delricht Moyer, Hendersonville

39503

Delricht Research at Gulfport Memorial, Gulfport

43213

Centricity Research, Columbus

44311

Synexus AES - Akron, Akron

48076

DM Clinical Research - Southfield, Southfield

60305

DM Clinical Research- River Forest, River Forest

65807

Delricht Research, Springfield

68516

Be Well Clinical Studies, LLC, Lincoln

68701

Velocity Clinical Research-Norfolk, Norfolk

70769

DelRicht Research @ Neighborhood Health, Prairieville

70809

Velocity Clinical Research-Baton Rouge, Baton Rouge

74133

Delricht Tate, Tulsa

75070

DELRICHT RESEARCH at ZOMNIR FAMILY MEDICINE, McKinney

77054

Javara Inc. /Privia Medical Group Gulf Coast, PLLC, Sugar Land

77065

DM Clinical Research - Houston, Houston

77375

DM Clinical Research, Tomball

83221

Bingham Memorial Hospital, Blackfoot

85258

Scottsdale Clinical Trials, Scottsdale

85260

Headlands Research, Inc., Scottsdale

90274

Peninsula Research Associates (PRA), Rolling Hills Estates

92120

Acclaim Clinical Research, San Diego

92503

Artemis Institute for Clinical Research, Riverside

94568

West Coast Research LLC, Dublin

02445

DM Clinical Research - Brookline, Brookline

All Listed Sponsors
lead

ModernaTX, Inc.

INDUSTRY

NCT06060457 - A Study to Evaluate the Safety and Immune Response of mRNA-1345, a Vaccine Targeting Respiratory Syncytial Virus (RSV), When Co-administered With a Fluzone HD, in Adults ≥65 Years of Age | Biotech Hunter | Biotech Hunter